We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Oncocross is a biotechnology company that discovers and develops novel drug candidates by leveraging an artificial intelligence (AI)-based drug development platform. Through its proprietary AI platform, 'ONCO AI', it conducts disease target identification, drug repurposing, and companion diagnostic marker development, primarily focusing on the development of oncology drugs and treatments for rare diseases.
온코크로스는 인공지능(AI) 기반 신약 개발 플랫폼을 활용하여 신약 후보물질을 발굴하고 개발하는 바이오 기업입니다. 자체 AI 플랫폼인 'ONCO AI'를 통해 질병 타겟 발굴, 약물 재창출 및 동반진단 마커 개발을 수행하며, 주로 항암제 및 희귀질환 치료제 개발에 집중하고 있습니다.